Ottawa, Canada-based BTG International Canada launched its DC Bead LUMI device in Canada on Dec. 5.
Here's what you need to know.
1. The DC Bead LUMI is a radiopaque embolic drug-eluting bead that can have doxorubicin loaded into it to treat hepatocellular carcinoma or irinotecan for treating malignant colorectal cancer.
2. The DC Bead LUMI is the next iteration of the DC Bead which BTG says is the market leading drug-eluting embolic bead.
3. The new model allows for real-time confirmation of the devices location throughout embolization.
4. Sunnybrook Health Sciences Centre in Toronto, Canada, performed the first procedure with the new device.